Page last updated: 2024-10-24

chloroquine and Diabetic Cardiomyopathies

chloroquine has been researched along with Diabetic Cardiomyopathies in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuan, X1
Xiao, YC1
Zhang, GP1
Hou, N1
Wu, XQ1
Chen, WL1
Luo, JD1
Zhang, GS1

Other Studies

1 other study available for chloroquine and Diabetic Cardiomyopathies

ArticleYear
Chloroquine improves left ventricle diastolic function in streptozotocin-induced diabetic mice.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Animals; Chloroquine; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Heart Ventricles;

2016